These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1457 related articles for article (PubMed ID: 3139757)
21. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
22. Cytokine stimulation of antibody-dependent cellular cytotoxicity (ADCC) enhances cytolytic but not binding capacity of peritoneal macrophages. Fehr HG; Fan S; Lötzerich H; Appell HJ Anticancer Res; 1990; 10(3):821-5. PubMed ID: 2114820 [TBL] [Abstract][Full Text] [Related]
23. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
24. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. Narumi S; Hamilton TA J Immunol; 1991 May; 146(9):3038-44. PubMed ID: 1901891 [TBL] [Abstract][Full Text] [Related]
25. Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Corradin SB; Fasel N; Buchmüller-Rouiller Y; Ransijn A; Smith J; Mauël J Eur J Immunol; 1993 Aug; 23(8):2045-8. PubMed ID: 7688311 [TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. Green SJ; Chen TY; Crawford RM; Nacy CA; Morrison DC; Meltzer MS J Immunol; 1992 Sep; 149(6):2069-75. PubMed ID: 1381395 [TBL] [Abstract][Full Text] [Related]
27. Phorbol ester-stimulated superoxide production by murine bone marrow-derived macrophages requires preexposure to cytokines. Phillips WA; Hamilton JA J Immunol; 1989 Apr; 142(7):2445-9. PubMed ID: 2538510 [TBL] [Abstract][Full Text] [Related]
28. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. Belosevic M; Davis CE; Meltzer MS; Nacy CA J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315 [TBL] [Abstract][Full Text] [Related]
29. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction. Xing Z; Zganiacz A; Santosuosso M J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658 [TBL] [Abstract][Full Text] [Related]
30. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming. Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203 [TBL] [Abstract][Full Text] [Related]
31. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity. Lewis CE; McCarthy SP; Lorenzen J; McGee JO Immunology; 1990 Mar; 69(3):402-8. PubMed ID: 2107146 [TBL] [Abstract][Full Text] [Related]
34. Failure to induce nitric oxide production by human monocyte-derived macrophages. Manipulation of biochemical pathways. Arias M; Zabaleta J; Rodríguez JI; Rojas M; París SC; García LF Allergol Immunopathol (Madr); 1997; 25(6):280-8. PubMed ID: 9469204 [TBL] [Abstract][Full Text] [Related]
35. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C; Strober W J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695 [TBL] [Abstract][Full Text] [Related]
36. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor. Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517 [TBL] [Abstract][Full Text] [Related]
37. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. Kumar R; Dong Z; Fidler IJ J Immunol; 1996 Dec; 157(11):5104-11. PubMed ID: 8943420 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide. Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323 [TBL] [Abstract][Full Text] [Related]
39. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. Lin JY; Chadee K J Immunol; 1992 Jun; 148(12):3999-4005. PubMed ID: 1318338 [TBL] [Abstract][Full Text] [Related]
40. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]